BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1
Zhenfeng Zhang(State Key Laboratory of Oncogene and Related Genes), Guanglei Zhuang(Shanghai Jiao Tong University)
Cited by 100
Related Papers
Tumour‐secreted miR‐9 promotes endothelial cell migration and angiogenesis by activating the JAK‐STAT pathway
|The EMBO Journal|2012|471
Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors
|Nature Communications|2018|153
Simultaneous evolutionary expansion and constraint of genomic heterogeneity in multifocal lung cancer
|Nature Communications|2017|78
Adaptive and Acquired Resistance to EGFR Inhibitors Converge on the MAPK Pathway
|Theranostics|2016|48
Concomitant BET and MAPK blockade for effective treatment of ovarian cancer
|Oncotarget|2015|34